Levels of specific immune complement proteins in blood and cerebrospinal fluid, including C3, factor B, and C5, showed strong potential for distinguishing people with neurosarcoidosis from those without the disease, according to a small study in the U.K. Combinations of several complement proteins yielded more discriminative potential, while combining…
A common genetic variant in the TNFR1 gene, which encodes a protein involved in regulating inflammation, may help identify people with sarcoidosis who are at higher risk of worsening lung function, a new study suggests. Researchers found that patients carrying two copies of the more common form of the…
Atyr Pharma plans to launch a new global clinical trial to test its investigational therapy, efzofitimod, in people with pulmonary sarcoidosis and a restrictive profile, in which the lungs cannot fully expand. The decision follows a type C meeting with the U.S. Food and Drug Administration (FDA) to discuss…
Becoming educated and informed about sarcoidosis is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your sarcoidosis journey.
There is no cure for sarcoidosis yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
